Literature DB >> 23510965

Epidemiology of drug-induced liver injury in China: a systematic analysis of the Chinese literature including 21,789 patients.

Yuan Zhou1, Li Yang, Zhongli Liao, Xiaoyang He, Yuanyuan Zhou, Hong Guo.   

Abstract

BACKGROUND: The epidemiology of drug-induced liver injury (DILI) in China has rarely been studied before. The aim of the present study was to determine the etiology of DILI in a Chinese population by reporting a systematic analysis of the Chinese literature published from 1994 to 2011.
METHODS: A comprehensive database search of the Chinese literature was performed to obtain all the relevant studies. The data, including the drug names and patients' sex, age, clinical classification, and prognosis, were collected and analyzed.
RESULTS: In this research, we found 279 studies including 24 112 patients. There were 265 studies that reported the sex of 21 789 patients, 11 787 men and 10 002 women. The therapeutics included (but were not limited to) tuberculostatics, complementary and alternative medicines (CAMs), antibiotics, NSAIDs, antineoplastics, central nervous system agents, antithyroid drugs, and immunomodulators. Of these drugs, tuberculostatics and CAMs were the most common etiologies of DILI in China.
CONCLUSION: DILI in China has a different etiology from that in Europe and USA. NSAIDs, which are the most common causes of DILI in western populations, are uncommon in China. Therefore, government, physicians, and patients should pay more attention to these drugs in DILI.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23510965     DOI: 10.1097/MEG.0b013e32835f6889

Source DB:  PubMed          Journal:  Eur J Gastroenterol Hepatol        ISSN: 0954-691X            Impact factor:   2.566


  38 in total

1.  Traditional Chinese medicine poisoning in the emergency departments in Hong Kong: Trend, clinical presentation and predictors for poor outcome.

Authors:  Rex Pui Kin Lam; Eric Ho Yin Lau; Wai Lam Yip; Joe Kai Shing Leung; Matthew Sik Hon Tsui
Journal:  World J Emerg Med       Date:  2021

Review 2.  Landscape of Liver Injury From Herbal and Dietary Supplements in Europe, Latin America, and Asia.

Authors:  Raul J Andrade
Journal:  Clin Liver Dis (Hoboken)       Date:  2019-09-02

3.  Acute hepatitis induced by a Chinese herbal product Qibao Meiran Wan: a case study.

Authors:  Xiaoyan Li; Caihong Qu; Qiong He; Wenying Chen; Xiaojuan Zhang; Xiaoqi Liu; Yuxing Liu; Yongbo Tang
Journal:  Int J Clin Exp Med       Date:  2015-07-15

Review 4.  Drug-Induced Liver Injury: Why is the Roussel Uclaf Causality Assessment Method (RUCAM) Still Used 25 Years After Its Launch?

Authors:  Gaby Danan; Rolf Teschke
Journal:  Drug Saf       Date:  2018-08       Impact factor: 5.606

5.  Ashwagandha-induced liver injury: A case series from Iceland and the US Drug-Induced Liver Injury Network.

Authors:  Helgi K Björnsson; Einar S Björnsson; Bharathi Avula; Ikhlas A Khan; Jon G Jonasson; Marwan Ghabril; Paul H Hayashi; Victor Navarro
Journal:  Liver Int       Date:  2020-02-11       Impact factor: 5.828

Review 6.  Traditional Chinese Medicine (TCM) and Herbal Hepatotoxicity: RUCAM and the Role of Novel Diagnostic Biomarkers Such as MicroRNAs.

Authors:  Rolf Teschke; Dominique Larrey; Dieter Melchart; Gaby Danan
Journal:  Medicines (Basel)       Date:  2016-07-19

Review 7.  Drug- and herb-induced liver injury: Progress, current challenges and emerging signals of post-marketing risk.

Authors:  Emanuel Raschi; Fabrizio De Ponti
Journal:  World J Hepatol       Date:  2015-07-08

8.  Characteristics and clinical outcome of nonsteroidal anti-inflammatory drug-induced acute hepato-nephrotoxicity among Chinese patients.

Authors:  Ya-Li Cao; Zhi-Gang Tian; Fang Wang; Wen-Ge Li; Dan-Ying Cheng; Yan-Fang Yang; Hong-Mei Gao
Journal:  World J Gastroenterol       Date:  2014-10-14       Impact factor: 5.742

Review 9.  Liver injury from herbal and dietary supplements.

Authors:  Victor J Navarro; Ikhlas Khan; Einar Björnsson; Leonard B Seeff; Jose Serrano; Jay H Hoofnagle
Journal:  Hepatology       Date:  2016-11-17       Impact factor: 17.425

10.  Prediction of oral hepatotoxic dose of natural products derived from traditional Chinese medicines based on SVM classifier and PBPK modeling.

Authors:  Size Li; Yiqun Yu; Xiaolan Bian; Li Yao; Min Li; Yan-Ru Lou; Jing Yuan; Hai-Shu Lin; Lucy Liu; Bing Han; Xiaoqiang Xiang
Journal:  Arch Toxicol       Date:  2021-03-13       Impact factor: 5.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.